StockWatch
·

Rani Therapeutics Holdings, Inc. Q1 FY26 Results

RANIQ1 FY26 Results
Filing
MetricValue ($ M)Q1 FY25
Revenue1.71905.9%
Total Income1.71905.9%
Expenditure10.0517.6%
PBT—
Net Profit-7.033.2%
OPM—
NPM—
EPS-0.0481.8%
View full financials

Informational and educational content only. Not investment advice.